A Phase I Randomised, Double-Blind, Placebo-Controlled, Single and Multiple Ascending Dose Study to Evaluate the Safety, Tolerability, Pharmacokinetics, Pharmacodynamics and Food Effect of WD-910 in Healthy Participants
Clinical trial NCT06897813 · NOT_YET_RECRUITING
Trial details
- NCT number
- NCT06897813
- Sponsor
- Zhejiang Wenda Pharma Technology LTD.
- Status
- NOT_YET_RECRUITING
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2025-06-30
- Primary completion
- 2025-10-31
- Enrollment
- 68
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.